These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29668411)

  • 1. Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.
    Pomper MG; Lee S
    Radiology; 2018 May; 287(2):590-591. PubMed ID: 29668411
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable?
    Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC
    Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage.
    Matsuo M; Kanematsu M; Kim T; Hori M; Takamura M; Murakami T; Kondo H; Moriyama N; Nakamura H; Hoshi H
    AJR Am J Roentgenol; 2003 Feb; 180(2):461-6. PubMed ID: 12540452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA.
    Nishie A; Asayama Y; Ishigami K; Tajima T; Kakihara D; Nakayama T; Takayama Y; Okamoto D; Taketomi A; Shirabe K; Fujita N; Obara M; Yoshimitsu K; Honda H
    J Magn Reson Imaging; 2012 Sep; 36(3):664-71. PubMed ID: 22532503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging.
    Matsuo M; Kanematsu M; Itoh K; Ito K; Maetani Y; Kondo H; Kako N; Matsunaga N; Hoshi H; Shiraishi J
    AJR Am J Roentgenol; 2001 Sep; 177(3):637-43. PubMed ID: 11517061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.
    Lee S; Choi D; Jeong WK
    J Magn Reson Imaging; 2016 Nov; 44(5):1339-1345. PubMed ID: 27197633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    Keller S; Aigner A; Zenouzi R; Kim AC; Meijer A; Weidemann SA; Krech T; Lohse AW; Adam G; Schramm C; Yamamura J
    PLoS One; 2018; 13(3):e0193929. PubMed ID: 29513767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hyperenhancement of confluent hepatic fibrosis on dynamic MR imaging.
    Ahn IO; de Lange EE
    AJR Am J Roentgenol; 1998 Sep; 171(3):901-2. PubMed ID: 9725360
    [No Abstract]   [Full Text] [Related]  

  • 14. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.
    Hagiwara M; Rusinek H; Lee VS; Losada M; Bannan MA; Krinsky GA; Taouli B
    Radiology; 2008 Mar; 246(3):926-34. PubMed ID: 18195377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI.
    Xie S; Sun Y; Wang L; Yang Z; Luo J; Wang W
    Acad Radiol; 2015 Apr; 22(4):460-6. PubMed ID: 25601305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness.
    Hallinan JT; Alsaif HS; Wee A; Venkatesh SK
    Abdom Imaging; 2015 Apr; 40(4):783-8. PubMed ID: 25331568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography.
    Wells ML; Moynagh MR; Carter RE; Childs RA; Leitch CE; Fletcher JG; Yeh BM; Venkatesh SK
    Abdom Radiol (NY); 2017 Jan; 42(1):191-198. PubMed ID: 27511365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation.
    Verloh N; Utpatel K; Haimerl M; Zeman F; Fellner C; Fichtner-Feigl S; Teufel A; Stroszczynski C; Evert M; Wiggermann P
    Sci Rep; 2015 Oct; 5():15408. PubMed ID: 26478097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
    Kanki A; Tamada T; Higaki A; Noda Y; Tanimoto D; Sato T; Higashi H; Ito K
    Magn Reson Imaging; 2012 Apr; 30(3):356-60. PubMed ID: 22227353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions.
    Macarini L; Marini S; Milillo P; Vinci R; Ettorre GC
    Radiol Med; 2006 Dec; 111(8):1087-102. PubMed ID: 17171525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.